| MeSH term | MeSH ID | Detail |
|---|---|---|
| Malocclusion | D008310 | 3 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Periodontal Diseases | D010510 | 15 associated lipids |
| Osteitis Deformans | D010001 | 3 associated lipids |
| Dental Pulp Necrosis | D003790 | 6 associated lipids |
| Crohn Disease | D003424 | 12 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| D'Abramo A et al. | Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. | 2016 | PLoS ONE | pmid:26913505 |
| Plasilova M et al. | Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). | 2011 | PLoS ONE | pmid:21738662 |
| Liu W et al. | Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. | 2015 | PLoS ONE | pmid:26571489 |
| Tao H et al. | P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. | 2011 | PLoS ONE | pmid:21886782 |
| Yang DC et al. | cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. | 2008 | PLoS ONE | pmid:18253488 |
| Lewis JR et al. | Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. | 2015 | PLoS ONE | pmid:26222774 |
| Wang J et al. | RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. | 2015 | PLoS ONE | pmid:26218592 |
| Lin C et al. | The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. | 2013 | PLoS ONE | pmid:23469146 |
| Benito-Martin A et al. | Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. | 2013 | PLoS ONE | pmid:24058411 |
| Morena M et al. | Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. | 2012 | PLoS ONE | pmid:22567137 |
| Ehlken C et al. | Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. | 2015 | PLoS ONE | pmid:25978399 |
| Bortolin RH et al. | Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. | 2015 | PLoS ONE | pmid:25933189 |
| Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
| Davaine JM et al. | Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. | 2014 | PLoS ONE | pmid:25259713 |
| Chen YH et al. | Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. | 2012 | PLoS ONE | pmid:22957004 |
| Tyagi AM et al. | Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. | 2012 | PLoS ONE | pmid:22970248 |
| Xue Y et al. | Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. | 2012 | PLoS ONE | pmid:23144698 |
| Gómez-Vaquero C et al. | Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. | 2016 | PLoS ONE | pmid:27911913 |
| Caetano-Lopes J et al. | Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. | 2011 | PLoS ONE | pmid:21347301 |
| Kassem A et al. | Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. | 2016 | PLoS ONE | pmid:27311019 |
| Djamiatun K et al. | Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. | 2012 | PLoS Negl Trop Dis | pmid:22563509 |
| Ryser MD et al. | Osteoprotegerin in bone metastases: mathematical solution to the puzzle. | 2012 | PLoS Comput. Biol. | pmid:23093918 |
| Beederman M et al. | Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. | 2015 | Plast. Reconstr. Surg. | pmid:26017615 |
| Xu Y et al. | Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. | 2010 | Planta Med. | pmid:20157877 |
| Oliver JL et al. | Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. | 2013 | Pigment Cell Melanoma Res | pmid:23490134 |
| Jang S et al. | Wogonin inhibits osteoclast formation induced by lipopolysaccharide. | 2010 | Phytother Res | pmid:19998398 |
| Tantikanlayaporn D et al. | A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. | 2013 | Phytomedicine | pmid:23557993 |
| Wang Y et al. | Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. | Phytomedicine | pmid:24854571 | |
| Bitto A et al. | Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. | 2011 | Phytomedicine | pmid:21397481 |
| Srivastava S et al. | Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. | 2013 | Phytomedicine | pmid:23570998 |
| Hsieh TP et al. | Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. | 2011 | Phytomedicine | pmid:20554188 |
| Wang F et al. | Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. | 2012 | Phytomedicine | pmid:22818561 |
| Chen B et al. | Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. | 2012 | Phytomedicine | pmid:22818895 |
| ZajÃcková K et al. | Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women? | 2008 | Physiol Res | pmid:18271681 |
| Xu M et al. | Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. | 2009 | Photomed Laser Surg | pmid:18800943 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Gradosova I et al. | The role of atorvastatin in bone metabolism in male albino Wistar rats. | 2011 | Pharmazie | pmid:21901984 |
| Wang GF et al. | Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. | 2006 | Pharmacology | pmid:16636611 |
| Gradosova I et al. | Protective effect of amlodipine on rat bone tissue after orchidectomy. | 2012 | Pharmacology | pmid:22302040 |
| Dawson S and Lawrie A | From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. | 2017 | Pharmacol. Ther. | pmid:27373854 |
| Treuheit MJ et al. | Inverse relationship of protein concentration and aggregation. | 2002 | Pharm. Res. | pmid:12033388 |
| Pipes GD et al. | Optimization and applications of CDAP labeling for the assignment of cysteines. | 2005 | Pharm. Res. | pmid:16028006 |
| Miyaji Y et al. | Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. | 2012 | Pharm. Res. | pmid:22729371 |
| Nemec K and Schubert-Zsilavecz M | [Future therapies for metabolic bone diseases. New concepts and targets]. | 2001 | Pharm Unserer Zeit | pmid:11715689 |
| Wang AY | Vascular and other tissue calcification in peritoneal dialysis patients. | 2009 | Perit Dial Int | pmid:19270239 |
| Bartold PM et al. | Mechanisms and control of pathologic bone loss in periodontitis. | 2010 | Periodontol. 2000 | pmid:20403105 |
| Nagasawa T et al. | Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. | 2007 | Periodontol. 2000 | pmid:17214836 |
| Petersson M et al. | Oxytocin stimulates proliferation of human osteoblast-like cells. | 2002 | Peptides | pmid:12126740 |
| Honsawek S et al. | Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. | 2009 | Pediatr. Surg. Int. | pmid:19184056 |
| Rosso DA et al. | Elevated serum levels of the decoy receptor osteoprotegerin in children with Langerhans cell histiocytosis. | 2006 | Pediatr. Res. | pmid:16439593 |
| Bargman R et al. | High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. | 2012 | Pediatr. Res. | pmid:22926546 |
| Vidal K et al. | Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. | 2004 | Pediatr. Res. | pmid:15155868 |
| Rianthavorn P et al. | Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. | 2010 | Pediatr. Nephrol. | pmid:20676692 |
| Wasilewska A et al. | Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. | 2010 | Pediatr. Nephrol. | pmid:20602239 |
| Siomou E et al. | Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. | 2011 | Pediatr. Nephrol. | pmid:21479768 |
| Ketteler M et al. | "Missing" inhibitors of calcification: general aspects and implications in renal failure. | 2005 | Pediatr. Nephrol. | pmid:15549415 |
| Swolin-Eide D et al. | The novel bone alkaline phosphatase B1x isoform in children with kidney disease. | 2006 | Pediatr. Nephrol. | pmid:16932897 |
| Angelopoulos NG et al. | Markers of bone metabolism in eugonadal female patients with beta-thalassemia major. | 2007 Oct-Nov | Pediatr Hematol Oncol | pmid:17786784 |
| Skordis N et al. | Hormonal dysregulation and bones in thalassaemia--an overview. | 2008 | Pediatr Endocrinol Rev | pmid:19337163 |
| Ishii R et al. | High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis. | 2006 | Pediatr Blood Cancer | pmid:16358318 |
| Quan J et al. | Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. | 2012 | Pathology | pmid:22406484 |
| Won KY et al. | RANK signalling in bone lesions with osteoclast-like giant cells. | 2011 | Pathology | pmid:21532526 |
| Levidou G et al. | TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. | 2013 | Pathology | pmid:23277172 |
| Chan MH et al. | Specific biochemical markers of bone metabolism and cytokine study confirm the diagnosis of malignant infantile osteopetrosis at birth using cord blood sample. | 2005 | Pathology | pmid:15875734 |
| Ikeda T et al. | Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells. | 2003 | Pathol. Int. | pmid:12828610 |
| Michou L et al. | [Molecular analysis of Paget's disease of bone]. | 2007 Apr-May | Pathol. Biol. | pmid:16884862 |
| Pietrapertosa AC et al. | Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major. | 2009 | Panminerva Med | pmid:19352306 |
| Gulseren A et al. | Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. | 2011 | Panminerva Med | pmid:21659972 |
| D'Amore M et al. | Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women. | 2006 | Panminerva Med | pmid:17215793 |
| Satoh K et al. | Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer. | 2001 | Pancreas | pmid:11590320 |
| Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
| Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
| Songia P et al. | Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. | 2017 | Oxid Med Cell Longev | pmid:28261377 |
| Kuczkowski J et al. | [Molecular control of bone resorption in chronic otitis media with cholesteatoma]. | 2010 Jul-Aug | Otolaryngol Pol | pmid:20873097 |
| Hamed AA and Fayad JN | Presence of otosclerosis and paget lesions in the same temporal bone. | 2009 | Otol. Neurotol. | pmid:19779387 |
| Jurado S et al. | Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. | 2010 | Osteoporos Int | pmid:19436932 |
| Hampson G et al. | Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial. | 2003 | Osteoporos Int | pmid:12904840 |
| Dobnig H et al. | Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients. | 2006 | Osteoporos Int | pmid:16435076 |
| Kananen K et al. | Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss? | 2006 | Osteoporos Int | pmid:16437190 |
| Ulivieri FM et al. | Increased osteoprotegerin in Italian haemodialysis patients. | 2006 | Osteoporos Int | pmid:17019516 |
| Jiang SD et al. | Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats. | 2007 | Osteoporos Int | pmid:17036173 |
| Findlay DM and Atkins GJ | Relationship between serum RANKL and RANKL in bone. | 2011 | Osteoporos Int | pmid:21850548 |
| Atkins GJ et al. | Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. | 2009 | Osteoporos Int | pmid:18763010 |
| Li YF et al. | The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. | 2012 | Osteoporos Int | pmid:21892678 |
| Zhao HY et al. | Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women. | 2008 | Osteoporos Int | pmid:17703270 |
| Dovio A et al. | Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis. | 2008 | Osteoporos Int | pmid:17703272 |
| Campbell GM et al. | Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. | 2011 | Osteoporos Int | pmid:20480144 |
| Wheater G et al. | Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. | 2011 | Osteoporos Int | pmid:21625887 |
| Zhang Y et al. | Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. | 2011 | Osteoporos Int | pmid:20414641 |
| Niu YB et al. | The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. | 2012 | Osteoporos Int | pmid:22535190 |
| Aubin JE and Bonnelye E | Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. | 2000 | Osteoporos Int | pmid:11193242 |
| Ominsky MS et al. | The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys. | 2007 | Osteoporos Int | pmid:17384898 |
| Kahl KG et al. | Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. | 2005 | Osteoporos Int | pmid:15300363 |
| Mezquita-Raya P et al. | The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. | 2005 | Osteoporos Int | pmid:15711777 |
| Zhao HY et al. | The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. | 2005 | Osteoporos Int | pmid:15782282 |
| Leder BZ and Finkelstein JS | Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. | 2005 | Osteoporos Int | pmid:15856361 |
| Indridason OS et al. | Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. | 2005 | Osteoporos Int | pmid:15776220 |
| Belaya ZE et al. | Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. | 2013 | Osteoporos Int | pmid:23358608 |
| Maïmoun L et al. | In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. | 2011 | Osteoporos Int | pmid:21359671 |
| Riggs BL et al. | Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency. | 2003 | Osteoporos Int | pmid:12879223 |